English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  50696425    ???header.onlineuser??? :  312
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"| tseng t c"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-10 of 26  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-07-12T02:44:49Z Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion HUNG-CHIH YANG; | Chen C.-L; | Shen Y.-C; | Peng C.-Y; | Liu C.-J; | Tseng T.-C; | Su T.-H; | Chuang W.-L; | Yu M.-L; | Dai C.-Y; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:48Z Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection Su T.-H; | Liu C.-J; | Tseng T.-C; | Liu C.-H; | HUNG-CHIH YANG; | Chen C.-L; | Chen P.-J; | Kao J.-H; | Chen D.-S.
臺大學術典藏 2021-07-12T02:44:46Z Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy Su T.-H; | Liu C.-J; | HUNG-CHIH YANG; | Jeng Y.-M; | Cheng H.-R; | Liu C.-H; | Tseng T.-C; | Ling T.-Y; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:43Z Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection Cheng H.-R; | Kao J.-H; | Wu H.-L; | Tseng T.-C; | Liu C.-H; | HUNG-CHIH YANG; | Su T.-H; | Chen P.-J; | Chen D.-S; | Liu C.-J.
臺大學術典藏 2021-07-12T02:44:41Z Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition Su T.-H; | Shiau C.-W; | Jao P; | Liu C.-H; | Liu C.-J; | Tai W.-T; | Jeng Y.-M; | HUNG-CHIH YANG; | Tseng T.-C; | Huang H.-P; | Cheng H.-R; | Chen P.-J; | Chen K.-F; | Kao J.-H; | Chen D.-S.
臺大學術典藏 2021-07-12T02:44:38Z Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection Yang W.-T; | Wu L.-W; | Tseng T.-C; | Chen C.-L; | HUNG-CHIH YANG; | Su T.-H; | Wang C.-C; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Liu C.-J; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:38Z Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:35Z Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis Su T.-H; | Shiau C.-W; | Jao P; | Yang N.-J; | Tai W.-T; | Liu C.-J; | Tseng T.-C; | HUNG-CHIH YANG; | Liu C.-H; | Huang K.-W; | Hu T.-C; | Huang Y.-J; | Wu Y.-M; | Chen L.-J; | Chen P.-J; | Chen D.-S; | Chen K.-F; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:33Z Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy Su T.-H; | HUNG-CHIH YANG; | Tseng T.-C; | Liou J.-M; | Liu C.-H; | Chen C.-L; | Chen P.-J; | Chen D.-S; | Liu C.-J; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:33Z Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan Liu C.-H; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Kao J.-H.

Showing items 1-10 of 26  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page